StockNews.AI
INSP
StockNews.AI
12 days

INSPIRE (INSP) ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Inspire Stockholders and Encourages Investors to Contact the Firm

1. Inspire Medical Systems slashed its earnings guidance for fiscal 2025 significantly. 2. Stock price fell $46.44 to $83.51 following earnings guidance announcement. 3. A law firm is investigating possible securities law violations by Inspire. 4. Issues cited include rollout delays and training failures affecting new product launches.

4m saved
Insight
Article

FAQ

Why Very Bearish?

The drastic reduction in earnings forecast typically suggests deeper operational issues. Historical examples show that similar guidance cuts often lead to sustained stock price declines.

How important is it?

The article focuses on significant earnings restructuring and potential legal challenges, both disruptive factors for INSP. These points are crucial for investor sentiment and company stability.

Why Short Term?

The immediate repercussions from earnings misses and legal investigations tend to affect stock prices. Historical cases validate that stock prices react swiftly to such news.

Related Companies

MDCOGILDPFE
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire (INSP) To Contact Him Directly To Discuss Their Options If you purchased or acquired Inspire stock and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE:INSP) on behalf of Inspire stockholders. Our investigation concerns whether Inspire has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On August 5, 2025, Inspire issued a press release announcing better-than-expected second quarter fiscal 2025 results, but surprisingly also slashed its full-year guidance from anticipated earnings of $2.20 - $2.30 on revenue of $940m - $955m down to earnings of $0.40 - $0.50 on revenue of $900m - $910m. This follows Inspire raising its earnings guidance only one quarter ago. Management blamed the guidance setback on slowdowns related to the recent rollout of Inspire V. The company disclosed that the commercial rollout "encountered certain headwinds" such as centers failing to complete training and onboarding criteria, customer delays, technical Medicare adoption delays, and continued higher demand for Inspire IV devices. Following this news, Inspire's stock price fell by $46.44 per share to open at $83.51 per share. If you purchased or otherwise acquired Inspire shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, South Carolina, and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X. Contact Information: Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Related News